Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus

References

• Chow V, Law S, Lam KY, et al. Telomerase activity in small cell esophageal carcinoma. Dis Esophagus. 2001;14:139–142. doi:10.1046/j.1442-2050.2001.00172.x11553225
   PubMed Web of Science ®Google Scholar
• Hosokawa A, Shimada Y, Matsumura Y, et al. Small cell carcinoma of the esophagus. Analysis of 14 cases and literature review. Hepato-Gastroenterology. 2005;52:1738–1741.16334769
   PubMedGoogle Scholar
• Bennouna J, Bardet E, Deguiral P, et al. Small cell carcinoma of the esophagus: analysis of 10 cases and review of the published data. Am J Clin Oncol. 2000;23:455–459.11039503
   PubMed Web of Science ®Google Scholar
• Medgyesy CD, Wolff RA, Putnam JB Jr., et al. Small cell carcinoma of the esophagus: the university of texas m. D. Anderson cancer center experience and literature review. Cancer. 2000;88(2):262–267. doi:10.1002/(SICI)1097-0142(20000115)88:2<262::AID-CNCR3>3.0.CO;2-K10640955
   PubMed Web of Science ®Google Scholar
• Xu L, Li Y, Liu X, et al. Treatment strategies and prognostic factors of limited-stage primary small cell carcinoma of the esophagus. J Thorac Oncol. 2017;12:1834–1844. doi:10.1016/j.jtho.2017.09.196629024756
   PubMed Web of Science ®Google Scholar
• Wong AT, Shao M, Rineer J, et al. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the national cancer data base. Dis Esophagus. 2017;30:1–5. doi:10.1111/dote.12487
   Web of Science ®Google Scholar
• Brenner B, Tang LH, Klimstra DS, et al. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22:2730–2739. doi:10.1200/JCO.2004.09.07515226341
   PubMed Web of Science ®Google Scholar
• Cicin I, Karagol H, Uzunoglu S, et al. Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study. Cancer. 2007;110:1068–1076. doi:10.1002/cncr.2288717614337
   PubMed Web of Science ®Google Scholar
• Ku GY, Minsky BD, Rusch VW, et al. Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the memorial sloan-kettering experience. Ann Oncol. 2008;19:533–537. doi:10.1093/annonc/mdm47617947223
   PubMed Web of Science ®Google Scholar
• Lv J, Liang J, Wang J, et al. Primary small cell carcinoma of the esophagus. J Thorac Oncol. 2008;3(12):1460–1465. doi:10.1097/JTO.0b013e31818e124719057273
   PubMed Web of Science ®Google Scholar
• Meng MB, Zaorsky NG, Jiang C, et al. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma. Radiother Oncol. 2013;106(3):317–322. doi:10.1016/j.radonc.2013.01.00823498325
   PubMed Web of Science ®Google Scholar
• Zhu Y, Qiu B, Liu H, et al. Primary small cell carcinoma of the esophagus: review of 64 cases from a single institution. Dis Esophagus. 2014;27(2):152–158. doi:10.1111/dote.1206923639106
   PubMed Web of Science ®Google Scholar
• Rice TW, Gress DM, Patil DT, et al. Cancer of the esophagus and esophagogastric junction-major changes in the american joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:304–317. doi:10.3322/caac.2139928556024
   PubMed Web of Science ®Google Scholar
• Stahel RA. Diagnosis, staging, and prognostic factors of small cell lung cancer. Curr Opin Oncol. 1991;3(2):306–311. doi:10.1097/00001622-199104000-000111648971
   PubMedGoogle Scholar
• Lawless J. Statistical Models and Methods for Lifetime Data. New York: Wiley; 1982.
   Google Scholar
• Vos B, Rozema T, Miller RC, et al. Small cell carcinoma of the esophagus: a multicentre rare cancer network study. Dis Esophagus. 2011;24:258–264. doi:10.1111/j.1442-2050.2010.01133.x21073624
   PubMed Web of Science ®Google Scholar
• Casas F, Ferrer F, Farrus B, et al. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer. 1997;80:1366–1372. doi:10.1002/(SICI)1097-0142(19971015)80:8<1366::AID-CNCR2>3.0.CO;2-D9338459
   PubMed Web of Science ®Google Scholar
• Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008;32:1404–1411. doi:10.1097/PAS.0b013e31816bf41f18670347
   PubMed Web of Science ®Google Scholar
• Wang HH, Zaorsky NG, Meng MB, et al. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. Onco Targets Ther. 2015;8:437–444. doi:10.2147/OTT.S7604825709477
   PubMed Web of Science ®Google Scholar
• Lam KY, Law S, Tung PH, et al. Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis. Arch Pathol Lab Med. 2000;124:228–233. doi:10.1043/0003-9985(2000)124<0228:ESCC>2.0.CO;210656731
   PubMed Web of Science ®Google Scholar
• Kukar M, Groman A, Malhotra U, et al. Small cell carcinoma of the esophagus: a seer database analysis. Ann Surg Oncol. 2013;20:4239–4244. doi:10.1245/s10434-013-3167-323943025
   PubMed Web of Science ®Google Scholar
• Xie MR, Xu SB, Sun XH, et al. Role of surgery in the management and prognosis of limited-stage small cell carcinoma of the esophagus. Dis Esophagus. 2015;28:476–482. doi:10.1111/dote.1223024787553
   PubMed Web of Science ®Google Scholar
• Nishimaki T, Suzuki T, Nakagawa S, et al. Tumor spread and outcome of treatment in primary esophageal small cell carcinoma. J Surg Oncol. 1997;64:130–134. doi:10.1002/(SICI)1096-9098(199702)64:2<130::AID-JSO8>3.0.CO;2-C9047250
   PubMed Web of Science ®Google Scholar
• Mitani M, Kuwabara Y, Shinoda N, et al. Long-term survivors after the resection of limited esophageal small cell carcinoma. Dis Esophagus. 2000;13:259–261. doi:10.1046/j.1442-2050.2000.00124.x11206646
   PubMed Web of Science ®Google Scholar
• Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the japan clinical oncology group study 9104. J Clin Oncol. 2002;20:3054–3060. doi:10.1200/JCO.2002.12.07112118018
   PubMed Web of Science ®Google Scholar
• Fried DB, Morris DE, Poole C, et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol. 2004;22:4837–4845. doi:10.1200/JCO.2004.01.17815570087
   PubMed Web of Science ®Google Scholar
• Suntharalingam M, Winter K, Ilson D, et al. Effect of the addition of cetuximab to paclitaxel, cisplatin, and radiation therapy for patients with esophageal cancer: the nrg oncology rtog 0436 Phase 3 randomized clinical trial. JAMA Oncol. 2017;3(11):1520–1528. doi:10.1001/jamaoncol.2017.159828687830
   PubMed Web of Science ®Google Scholar
• Jeene PM, Geijsen ED, Muijs CT, et al. Small cell carcinoma of the esophagus: a nationwide analysis of treatment and outcome at patient level in locoregional disease. Am J Clin Oncol. 2019;42:534–538. doi:10.1097/COC.000000000000054631021827
   PubMed Web of Science ®Google Scholar
• Curran WJ Jr., Paulus R, Langer CJ, et al. Sequential vs. Concurrent chemoradiation for stage iii non-small cell lung cancer: randomized phase iii trial rtog 9410. J Natl Cancer Inst. 2011;103:1452–1460. doi:10.1093/jnci/djr32521903745
   PubMedGoogle Scholar
• Li F, Li T, Liu L, et al. Concurrent versus sequential chemoradiotherapy for esophageal cancer among chinese population: a meta-analysis. Tumori. 2015;101(4):353–359. doi:10.5301/tj.500031425983094
   PubMed Web of Science ®Google Scholar
• Chen B, Yang H, Ma H, et al. Radiotherapy for small cell carcinoma of the esophagus: outcomes and prognostic factors from a retrospective study. Rad Oncol. 2019;14:210. doi:10.1186/s13014-019-1415-9
   PubMed Web of Science ®Google Scholar
• Kristina SA, Endarti D, Wiedyaningsih C, et al. Estimating the burden of cancer and treatment cost related to alcohol consumption in indonesia: a descriptive study. Asian Pac j Cancer Prev. 2018;19:1845–1849. doi:10.22034/APJCP.2018.19.7.184530049196
   PubMedGoogle Scholar
• Lee WT, Hsiao JR, Ou CY, et al. The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol-metabolizing genes on the survival of head and neck cancer patients. Cancer Epidemiol Biomark Prev. 2019;28:248–257. doi:10.1158/1055-9965.EPI-18-0425
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu M, Ke ZJ, et al. Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer. Pharmacol Res. 2017;115:299–308. doi:10.1016/j.phrs.2016.12.00527939360
   PubMed Web of Science ®Google Scholar
• Zou B, Li T, Zhou Q, et al. Adjuvant therapeutic modalities in primary small cell carcinoma of esophagus patients: A retrospective cohort study of multicenter clinical outcomes. Medicine. 2016;95:e3507. doi:10.1097/MD.000000000000350727124057
   PubMed Web of Science ®Google Scholar
• Xu X, Yang Y, Cao L, et al. Lymph node metastasis and recurrence in primary small cell carcinoma of the esophagus: a retrospective study of 125 cases. Cancer Biother Radiopharm. 2019;34:459–463. doi:10.1089/cbr.2019.280031120315
   PubMed Web of Science ®Google Scholar